Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roden

Showing results (531-540 of 1,011) with videos related to

Pageof 102
Sort By:
European Heart Journal|August 9, 2021
Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance studyJoe-Elie Salem, Lee S Nguyen, Javid J Moslehi, et al.
Diabetologia|August 10, 2004
Brain energy metabolism during hypoglycaemia in healthy and type 1 diabetic subjectsM G Bischof, V Mlynarik, A Brehm, et al.
Pediatric Research|March 7, 2003
Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndromeWalter H Johnson, Ping Yang, Tao Yang, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2001
Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6-phosphate concentration in humansM Krebs, M Krssak, P Nowotny, et al.
Plos One|March 3, 2012
Characterization of genome-wide association-identified variants for atrial fibrillation in African AmericansJessica T Delaney, Janina M Jeff, Nancy J Brown, et al.
Scientific Reports|November 19, 2016
Genomic contributors to atrial electroanatomical remodeling and atrial fibrillation progression: Pathway enrichment analysis of GWAS dataDaniela Husser, Laura Ueberham, Borislav Dinov, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
A clinical algorithm to identify people with the glucose-6-phosphate dehydrogenase p.Val68Met variant at risk for diabetes undertreatmentYash Pershad, Joseph H Breeyear, Robert W Corty, et al.
Nature Communications|September 27, 2024
ParSE-seq: a calibrated multiplexed assay to facilitate the clinical classification of putative splice-altering variantsMatthew J O'Neill, Tao Yang, Julie Laudeman, et al.
American Heart Journal|March 1, 1984
Molecular basis for the antigenicity of lidocaine analogs: tocainide and mexiletineH J Duff, D M Roden, S Marney, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 9, 2019
Distinct trajectories of HbA<sub>1c</sub> in newly diagnosed Type 2 diabetes from the DPV registry using a longitudinal group-based modelling approachW Rathmann, A Schwandt, J M Hermann, et al.
Pageof 102

Showing results (531-540 of 1,011) with videos related to

Sort By:
Pageof 102
European Heart Journal|August 9, 2021
Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance studyJoe-Elie Salem, Lee S Nguyen, Javid J Moslehi, et al.
Diabetologia|August 10, 2004
Brain energy metabolism during hypoglycaemia in healthy and type 1 diabetic subjectsM G Bischof, V Mlynarik, A Brehm, et al.
Pediatric Research|March 7, 2003
Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndromeWalter H Johnson, Ping Yang, Tao Yang, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2001
Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6-phosphate concentration in humansM Krebs, M Krssak, P Nowotny, et al.
Plos One|March 3, 2012
Characterization of genome-wide association-identified variants for atrial fibrillation in African AmericansJessica T Delaney, Janina M Jeff, Nancy J Brown, et al.
Scientific Reports|November 19, 2016
Genomic contributors to atrial electroanatomical remodeling and atrial fibrillation progression: Pathway enrichment analysis of GWAS dataDaniela Husser, Laura Ueberham, Borislav Dinov, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
A clinical algorithm to identify people with the glucose-6-phosphate dehydrogenase p.Val68Met variant at risk for diabetes undertreatmentYash Pershad, Joseph H Breeyear, Robert W Corty, et al.
Nature Communications|September 27, 2024
ParSE-seq: a calibrated multiplexed assay to facilitate the clinical classification of putative splice-altering variantsMatthew J O'Neill, Tao Yang, Julie Laudeman, et al.
American Heart Journal|March 1, 1984
Molecular basis for the antigenicity of lidocaine analogs: tocainide and mexiletineH J Duff, D M Roden, S Marney, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 9, 2019
Distinct trajectories of HbA<sub>1c</sub> in newly diagnosed Type 2 diabetes from the DPV registry using a longitudinal group-based modelling approachW Rathmann, A Schwandt, J M Hermann, et al.
Pageof 102